Q2 2026 Holdings
Filed 2026-08-14 | 33 holdings | $3.3B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $1.1B | 8,493,321 | 34.2% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $394.8M | 4,148,428 | 12.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $327.8M | 17,891,812 | 9.9% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $265.0M | 2,985,448 | 8.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $115.0M | 1,180,000 | 3.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $101.6M | 10,346,926 | 3.1% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $93.7M | 3,603,595 | 2.8% |
| Savara Inc(SVRA) | COM | 805111101 | $90.8M | 14,745,943 | 2.8% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $71.6M | 3,220,364 | 2.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $63.6M | 1,642,166 | 1.9% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $59.8M | 3,257,917 | 1.8% |
| VOR Biopharma Inc(VOR) | COM NEW | 929033207 | $56.0M | 3,041,719 | 1.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $48.3M | 2,173,913 | 1.5% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $47.8M | 1,602,034 | 1.4% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $47.4M | 6,844,305 | 1.4% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $46.8M | 4,319,765 | 1.4% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $38.4M | 2,133,576 | 1.2% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $38.0M | 6,434,990 | 1.2% |
| Adlai Nortye LTD(ANL) | SPONSORED ADS | 00704R109 | $36.9M | 3,212,731 | 1.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $26.7M | 526,331 | 0.8% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $25.5M | 3,851,654 | 0.8% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $25.1M | 1,379,965 | 0.8% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $21.3M | 8,695,652 | 0.6% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $19.8M | 2,043,596 | 0.6% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $18.7M | 4,982,124 | 0.6% |
| Achieve Life Science Inc(ACHV) | COM | 004468500 | $18.0M | 2,751,032 | 0.5% |
| Parabilis Medicines Inc(PBLS) | COM | 698955101 | $17.1M | 625,000 | 0.5% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $16.4M | 632,931 | 0.5% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $13.3M | 1,009,500 | 0.4% |
| Alto Neuroscience Inc(ANRO) | COM SHS | 02157Q109 | $13.2M | 500,000 | 0.4% |
| X4 Pharmaceuticals Inc(XFOR) | COM NEW | 98420X202 | $9.0M | 1,934,253 | 0.3% |
| Research Alliance Corp III | ORD SHS CL A | G75226103 | $3.2M | 300,000 | 0.1% |
| Inmed Pharmaceuticals Inc(INM) | COM NEW | 457637700 | $50.7K | 32,685 | 0.0% |